Authors: Lofland, JH Kim, SS Batenhorst, AS Johnson, NE Chatterton, ML Cady, RK Kaniecki, R Nash, DB

Citation: Jh. Lofland et al., Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine, MAYO CLIN P, 76(11), 2001, pp. 1093-1101

Authors: Paddock, LE Veloski, J Chatterton, ML Gevirtz, FO Nash, DB

Citation: Le. Paddock et al., Development and validation of a questionnaire to evaluate patient satisfaction with diabetes disease management, DIABET CARE, 23(7), 2000, pp. 951-956

Authors: Lolfand, JH Touch, SM O'Connor, JP Chatterton, ML Moxey, ED Paddock, LE Nash, DB Desai, SA

Citation: Jh. Lolfand et al., Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: A cost-effectiveness analysis, CLIN THER, 22(11), 2000, pp. 1357-1369

Authors: Chatterton, ML Scott-Lennox, J Wu, AW Scott, J

Citation: Ml. Chatterton et al., Quality of life and treatment satisfaction after the addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens in treatment-experienced patients with HIV infection, PHARMACOECO, 15, 1999, pp. 67-74